Lodoxamide Tromethamine Production Cost Reports

The report provides a detailed analysis essential for establishing a Lodoxamide Tromethamine production plant. It encompasses all critical aspects necessary for Lodoxamide Tromethamine production, including the cost of Lodoxamide Tromethamine production, Lodoxamide Tromethamine plant cost, Lodoxamide Tromethamine production costs, and the overall Lodoxamide Tromethamine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Lodoxamide Tromethamine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Lodoxamide tromethamine is a mast-cell stabiliser primarily used to treat eye allergies and inflammation. It is widely used as an eye drop solution to treat allergic conjunctivitis for relieving symptoms like itching, redness, and swelling of the eyes caused by allergies.

Its ability to stabilise mast cells and prevent the release of histamine makes it effective in controlling allergic reactions. Additionally, Lodoxamide tromethamine is also used in the management of other allergic eye conditions. It is also sometimes used in combination treatments for patients with chronic ocular allergies. It is also explored for its potential in treating other inflammatory conditions affecting the eyes. It is often used in research aimed at improving eye care treatments and developing new formulations for better delivery and longer-lasting effects.

The demand for Lodoxamide Tromethamine is mainly driven by its use as an ophthalmic active ingredient for treating allergic eye conditions, which contributes to its market expansion. Its demand as a medication in the treatment of allergic conjunctivitis and vernal keratoconjunctivitis also supports its growth in the ophthalmic pharmaceutical market. Its usage as an important ingredient in prescription eye-drop formulations used in clinics and hospitals for reducing eye irritation and inflammation further boosts its demand in the medical and pharmaceutical industry.

Rising cases of seasonal and chronic eye allergies also strengthen its market demand. Industrial Lodoxamide tromethamine procurement is influenced by factors such as the availability and cost of key raw materials, adherence to strict pharmaceutical regulations, and quality-control standards. In addition, advancements in sterile formulation technologies, supplier consistency, sustainability requirements, and efficient distribution networks significantly impact its global procurement practices.

Raw Material for Lodoxamide Tromethamine Production

According to the Lodoxamide Tromethamine production plant project report, the major raw materials for Lodoxamide 4-chloro-3,5-dinitrobenzonitrile and Stannous Chloride Dihydrate-Triethylamine-Ethyloxalyl Chloride.

Production Process of Lodoxamide Tromethamine

The extensive Lodoxamide Tromethamine production cost report consists of the following industrial production process:
 

1. Production via Reduction: The production process of Lodoxamide starts with reducing 4-chloro-3,5-dinitrobenzonitrile by using stannous chloride dihydrate in concentrated hydrochloric acid to obtain 4-chloro-3,5-diaminobenzonitrile. Then, 4-chloro-3,5-diaminobenzonitrile is isolated by basifying the reaction mixture, extracting with ethyl acetate, and recrystallising the solid. Further, the diamine is dissolved in dry DMF and treated with triethylamine, followed by the controlled addition of ethyloxalyl chloride at low temperature to form diethyl N,N'-(2-chloro-5-cyano-m-phenylene)dioxamate. After the reaction is complete, the mixture is filtered, concentrated, and poured into water to isolate the crude product, which is purified by recrystallisation. As the last step, this diethyl dioxamate is hydrolysed by extraction with sodium hydroxide, and the resulting aqueous layer is acidified to precipitate N,N'-(2-chloro-5-cyano-m-phenylene)dioxamic acid, which is also known as Lodoxamide. Finally, the obtained compound is collected and washed to obtain the purified Lodoxamide as the desired product.

Lodoxamide tromethamine appears as a white to off-white crystalline powder with no notable odour, and it dissolves readily in water. The compound has the molecular formula C19H28ClN5O12 and a molar mass of roughly 553.9 g/mol. The boiling point of the compound is about 827 degree Celsius, and its flash point is around 454 degree Celsius. It is generally handled as a dry solid or in aqueous solution. Its behaviour reflects the characteristics of a stable, highly functionalized organic salt used as an active ingredient in ophthalmic preparations. It is widely marketed under the brand name Alomide.